<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/P/Pemetrexed.html">
<title>Pemetrexed RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/P/Pemetrexed.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2012-02-09T08:26+29:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Pemetrexed RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/dmleotod9/statuses/167098395385802752" />
  <rdf:li rdf:resource="http://twitter.com/On_Col/statuses/166926402015330304" />
  <rdf:li rdf:resource="http://twitter.com/oncology23/statuses/166415677840826368" />
  <rdf:li rdf:resource="http://twitter.com/SympoOncology/statuses/166409172676644864" />
  <rdf:li rdf:resource="http://twitter.com/pubmedstream/statuses/166243787075633152" />
  <rdf:li rdf:resource="http://twitter.com/pubmedstream/statuses/166236235889770498" />
  <rdf:li rdf:resource="http://twitter.com/SympoPharmaco/statuses/165898950455463936" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/dmleotod9/statuses/167098395385802752">
<title>5-Fluorouracil / Capecitabine / Gemcitabine / Fludaradine / Pemetrexed / Methotrexate</title>
<link>http://twitter.com/dmleotod9/statuses/167098395385802752</link>
<description><![CDATA[5-Fluorouracil / Capecitabine / Gemcitabine / Fludaradine / Pemetrexed / Methotrexate]]></description>
</item>

<item rdf:about="http://twitter.com/On_Col/statuses/166926402015330304">
<title>#pemetrexed en c&#xC3;&#xA1;ncer de vejiga metastasico en tercera o cuarta  limea mejora e intervalos libres de progresi&#xC3;&#xB3;n  y la supervivencia global</title>
<link>http://twitter.com/On_Col/statuses/166926402015330304</link>
<description><![CDATA[#pemetrexed en cáncer de vejiga metastasico en tercera o cuarta  limea mejora e intervalos libres de progresión  y la supervivencia global]]></description>
</item>

<item rdf:about="http://twitter.com/oncology23/statuses/166415677840826368">
<title>RT @SympoOncology: Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/AQ6RQjaY</title>
<link>http://twitter.com/oncology23/statuses/166415677840826368</link>
<description><![CDATA[RT @SympoOncology: Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/AQ6RQjaY]]></description>
</item>

<item rdf:about="http://twitter.com/SympoOncology/statuses/166409172676644864">
<title>Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/AQ6RQjaY</title>
<link>http://twitter.com/SympoOncology/statuses/166409172676644864</link>
<description><![CDATA[Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/AQ6RQjaY]]></description>
</item>

<item rdf:about="http://twitter.com/pubmedstream/statuses/166243787075633152">
<title>[Pemetrexed as second-line treatment and beyond for elderly patients with advanced non-small-cell lung cancer].</title>
<link>http://twitter.com/pubmedstream/statuses/166243787075633152</link>
<description><![CDATA[[Pemetrexed as second-line treatment and beyond for elderly patients with advanced non-small-cell lung cancer].]]></description>
</item>

<item rdf:about="http://twitter.com/pubmedstream/statuses/166236235889770498">
<title>A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma.</title>
<link>http://twitter.com/pubmedstream/statuses/166236235889770498</link>
<description><![CDATA[A phase II trial of second-line pemetrexed in adults with advanced/metastatic osteosarcoma.]]></description>
</item>

<item rdf:about="http://twitter.com/SympoPharmaco/statuses/165898950455463936">
<title>Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/1oq6CkI8</title>
<link>http://twitter.com/SympoPharmaco/statuses/165898950455463936</link>
<description><![CDATA[Pemetrexed Continuation Maintenance slows lung cancer progression, Study showed 38% decrease in risk of progression http://t.co/1oq6CkI8]]></description>
</item>

</rdf:RDF>
